Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abhijit Parolia

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Molecular Oncology|January 27, 2016
Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progressionFrancesco Crea, Luca Quagliata, Agnieszka Michael, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Deciphering the Transcription Factor Landscape in Neuroendocrine Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
The Journal of Biological Chemistry|June 29, 2026
PAX8 controls proximal tubule epithelial identity and stress response through epigenetic modification of distal regulatory elementsAsha C Telang, Ma Wan, Steven K Orban, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 17, 2025
Deciphering the Transcription Factor Landscape in Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
Cancer Research|August 24, 2018
Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate CancerLanbo Xiao, Jean C Tien, Josh Vo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 17, 2023
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory responseYuanyuan Qiao, Jesse W Wotring, Yang Zheng, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancerJie Luo, Zhixiang Chen, Yuanyuan Qiao, et al.
Science (New York, N.Y.)|June 26, 2025
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticitySanjana Eyunni, Rahul Mannan, Yuping Zhang, et al.
Molecular Oncology|April 1, 2021
The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanismsRebecca L Mather, Abhijit Parolia, Sandra E Carson, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven MalignanciesTongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Molecular Oncology|January 27, 2016
Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progressionFrancesco Crea, Luca Quagliata, Agnieszka Michael, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Deciphering the Transcription Factor Landscape in Neuroendocrine Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
The Journal of Biological Chemistry|June 29, 2026
PAX8 controls proximal tubule epithelial identity and stress response through epigenetic modification of distal regulatory elementsAsha C Telang, Ma Wan, Steven K Orban, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 17, 2025
Deciphering the Transcription Factor Landscape in Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
Cancer Research|August 24, 2018
Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate CancerLanbo Xiao, Jean C Tien, Josh Vo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 17, 2023
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory responseYuanyuan Qiao, Jesse W Wotring, Yang Zheng, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancerJie Luo, Zhixiang Chen, Yuanyuan Qiao, et al.
Science (New York, N.Y.)|June 26, 2025
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticitySanjana Eyunni, Rahul Mannan, Yuping Zhang, et al.
Molecular Oncology|April 1, 2021
The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanismsRebecca L Mather, Abhijit Parolia, Sandra E Carson, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven MalignanciesTongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
Pageof 6